Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes
Hongyan Liu, Vikas S. Sridhar, Daniel Montemayor, Leif Erik Lovblom, Yuliya Lytvyn, Hongping Ye, Jiwan Kim, Mir Tariq Ali, Daniel Scarr, Patrick R. Lawler, Bruce A. Perkins, Kumar Sharma, David Z.I. Cherney
Profundice en los temas de investigación de 'Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes'. En conjunto forman una huella única.